Meta Platforms and Tesla headline Wednesday’s reports, with investors focused on whether AI investment can keep driving growth while Tesla’s core auto business weakens. m.
32 est. vs.
38 billion est. vs.
1% below its 52-week highAnalyst view: Buy consensus, $213 target (6 analysts)Philip Morris is expected to extend growth as smoke-free products supplement its combustible business, with the stock already near its 52-week high. It has beaten estimates in all of its past eight quarters.
In Q2, it beat on both EPS and revenue. On its July call, management highlighted 8% organic revenue growth and strong momentum in IQOS, ZYN and VEEV.
m. 40 est.
vs. 93 billion est.
vs. 9% below its 52-week highAnalyst view: Buy consensus, $637 target (14 analysts)Thermo Fisher is expected to build on improving customer activity and acquisition-driven growth, with the stock trading close to its 52-week high.
It has beaten estimates in all of its past eight quarters. In Q2, it beat on both EPS and revenue.
On its July call, management pointed to strong second-half momentum and raised its full-year revenue and adjusted EPS guidance. Morgan Stanley maintained its Overweight rating while raising its target to $730 from $650 on Oct.
m. 42 est.
vs. 99 billion est.
vs. 9% below its 52-week highAnalyst view: Buy consensus, $124 target (14 analysts)Abbott is expected to show whether its diversified health-care portfolio can regain momentum after a steep year-to-date decline in the stock.
In Q2, it beat on both EPS and revenue. On its July call, management reaffirmed its comparable-sales growth outlook and raised full-year EPS guidance.
TD Cowen reiterated its Buy rating and $135 target on Oct. m.
18 est. vs.
91 billion est. vs.
1% below its 52-week highAnalyst view: Buy consensus, $93 target (10 analysts)NextEra is expected to show whether renewable development and large-load demand can offset pressure reflected in a stock that remains well below its 52-week high. In Q2, it beat on EPS but missed revenue.
On its July call, management emphasized renewable expansion and large-load demand as growth drivers. BMO Capital maintained its Outperform rating while cutting its target to $88 from $93 on Oct.
m. 60 est.
vs. 65 billion est.
vs. 5% below its 52-week highAnalyst view: Buy consensus, $28 target (10 analysts)AT&T is expected to show whether subscriber and fiber momentum can stabilize a stock hit by a recent slide.
In Q2, it beat on EPS but missed revenue. On its July call, management pointed to more than 1 million advanced-connectivity additions, record fiber and fixed-wireless net adds, and improving operating leverage.
Scotiabank maintained its Sector Perform rating while cutting its target to $26 from $28 on Oct. m.
89 est. vs.
36 billion est. vs.
7% below its 52-week highAnalyst view: Buy consensus, $806 target (27 analysts)Meta is expected to deliver another sharp revenue expansion while absorbing heavier AI investment and a lower year-ago EPS comparison. It has beaten estimates in seven of its past eight quarters.
In Q2, it missed on EPS but beat revenue. On its July call, management emphasized ad performance, engagement growth and major investments in AI agents and data-center capacity.
Rosenblatt maintained its Buy rating and $886 target on Oct. m.
40 est. vs.
04 billion est. vs.
8% below its 52-week highAnalyst view: Buy consensus, $403 target (20 analysts)Tesla is expected to face a tougher test on vehicle profitability and demand as investors weigh its autonomous-driving and energy ambitions against a weakening earnings setup. In Q2, it missed on EPS but beat revenue.
On its July call, management highlighted record deliveries and continued investment in Robotaxi, Optimus and energy initiatives. Cantor Fitzgerald reiterated its Overweight rating and $485 target on Oct.
m. 18 est.
vs. 13 billion est.
vs. 6% below its 52-week highAnalyst view: Buy consensus, $395 target (17 analysts)Lam Research is expected to show whether AI-driven wafer-fabrication spending can support rapid growth after a sharp pullback from the stock’s 52-week high.
It has beaten estimates in all of its past eight quarters. In Q4, it beat on both EPS and revenue.
On its July call, management pointed to record results and strong AI-led wafer-fabrication equipment demand into 2027. Evercore ISI Group maintained its Outperform rating while cutting its target to $315 from $355 on Oct.
m. 03 est.
vs. 49 billion est.
vs. 9% below its 52-week highAnalyst view: Buy consensus, $229 target (3 analysts)SAP is expected to show whether cloud growth can keep rebuilding confidence after the stock’s year-to-date decline.
It has beaten estimates in six of its past eight quarters. In Q2, it missed on both EPS and revenue.
Barclays maintained its Overweight rating while raising its target to $243 from $242 on Oct. m.
42 est. vs.
92 billion est. vs.
6% below its 52-week highAnalyst view: Buy consensus, $334 target (20 analysts)Texas Instruments is expected to extend its semiconductor recovery, with industrial, automotive and data-center demand central to the read-through after a strong stock run. It has beaten estimates in six of its past eight quarters.
In Q2, it beat on both EPS and revenue. On its July call, management cited broad-based growth and projected above-seasonal Q3 expansion.
Wells Fargo maintained its Equal-Weight rating while cutting its target to $300 from $310 on Oct.
